Nine Diagnostics
PrivateLast Round
Grant
Jun 29, 2026
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nine Diagnostics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in June 2026.
Nine Diagnostics is a biotechnology company that develops AI-enabled nanosensor technology for functional precision medicine to determine treatment effectiveness and discover new biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Sensors
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nine Diagnostics Comparables
Compare Nine Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novigenix AI | 79% | |
| Xemperia SA | 79% | |
| Precede Biosciences | 78% |
For institutional investors. Book with your work email.
Nine Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 29, 2026 | ||||
| Pre Seed | Jan 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nine Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Gray Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 44% MoM, reaching 1.3K.
- Jun 29, 2026
Received funding from The Gray Foundation.
For institutional investors. Book with your work email.
Nine Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nine Diagnostics's valuation, stock price, and market status.
Is Nine Diagnostics a public or private company?
Nine Diagnostics is a private company.
What is the current stock price of Nine Diagnostics?
Nine Diagnostics is a private company, so its shares have no public market price. Caplight tracks Nine Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nine Diagnostics worth (valuation)?
Valuation information for Nine Diagnostics is not publicly available.
Can I buy Nine Diagnostics stock?
Nine Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nine Diagnostics's last funding round?
Nine Diagnostics's most recent funding round was Grant on June 29, 2026.
Who are the main investors in Nine Diagnostics?
Key investors in Nine Diagnostics include The Gray Foundation.
Will Nine Diagnostics IPO soon?
No public IPO plans have been announced for Nine Diagnostics.
How can I track Nine Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Nine Diagnostics's shares on secondary markets.